PhAST - aka PhAST Diagnostics - is a seed-stage AI healthcare company developing computer vision technology for rapid pathogen identification and antibiotic resistance detection directly from patient samples. The firm's platform is designed to provide clinical decision support for doctors, workflow improvement for hospitals, and helps accelerate the drug development process for pharmaceutical companies. Management believes that innovative technology can transform the way infectious diseases can be tackled. To that end, PhAST is developing rapid diagnostic technology to provide actionable information on pathogens, with the ultimate goal of making the world a healthier place. PhAST brings the power of single-cell imaging to microbiology, harnessing the immediate and extensive information that imaging reveals about microorganisms. The firm's multidisciplinary team is structured around bringing to bear a broad range of diagnostic testing approaches through single-cell imaging, to massively accelerate the detection, identification and antibiotic susceptibility testing of pathogens from days down to minutes.
